$7.66
0.192.54%
Pre-Market: 6:51 PM EDT
15 minutes delayed
Verrica Pharmaceuticals
VRCANASDAQ
Verrica Pharmaceuticals (VRCA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVerrica Pharmaceuticals (NASDAQ:VRCA) Stock Quotes, Forecast and News Summary
Verrica Pharmaceuticals Stock (NASDAQ: VRCA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 229.14K |
| Day Range | - - - |
| 52 Wk Range | 2.86 - 11.41 |
| Market Cap | $324.94M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 48 |
| Short Interest | 19.05% |
| Days to Cover | 21.22 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Verrica Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and com...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verrica Pharmaceuticals (VRCA) stock?
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Who are Verrica Pharmaceuticals (VRCA) competitors?
Other companies in Verrica Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the target price for Verrica Pharmaceuticals (VRCA) stock?
There is no analysis for Verrica Pharmaceuticals.
What is the forecast for Verrica Pharmaceuticals (VRCA) stock?
Verrica Pharmaceuticals has a consensus price target of $12.29.
Current stock price for Verrica Pharmaceuticals (VRCA)?
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $7.66 last updated July 2, 2024 at 6:51 PM EDT.
Does Verrica Pharmaceuticals (VRCA) pay a dividend?
There are no upcoming dividends for Verrica Pharmaceuticals.
When is Verrica Pharmaceuticals (NASDAQ:VRCA) reporting earnings?
Verrica Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Verrica Pharmaceuticals (VRCA) going to split?
There is no upcoming split for Verrica Pharmaceuticals.
What sector and industry does Verrica Pharmaceuticals (VRCA) operate in?
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.